BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17891357)

  • 1. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
    Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
    Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of an Early Kaposi's Sarcoma Case Post Kidney Transplantation by Sirolimus: A Case Report.
    Najafi F; Kafaie P; Neamatzadeh H
    Acta Med Iran; 2017 Feb; 55(2):139-141. PubMed ID: 28282713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment.
    Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.
    Descoeudres B; Giannini O; Graf T; Steiger J; Mayr M
    Transplantation; 2006 May; 81(10):1472-4. PubMed ID: 16732189
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
    Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
    Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
    [No Abstract]   [Full Text] [Related]  

  • 10. Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients.
    Aebischer MC; Zala LB; Braathen LR
    Dermatology; 1997; 195(1):91-2. PubMed ID: 9267755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
    Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
    Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaposi's sarcoma in patients with kidney transplantation].
    Vlasić-Matas J; Rumboldt Z; Puizina-Ivić N; Luksić B; Milas I; Dubravcić M; Forempoher G
    Lijec Vjesn; 1994; 116(3-4):95-7. PubMed ID: 8057746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM; Schena FP
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
    Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
    Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous Kaposi's sarcoma with pulmonary carcinomatous lymphangitis in patient with heart transplantation].
    Philit F; Mornex JF; Dureau G; Chuzel M; Euvrard S; Ecochard D; Brune J
    Rev Mal Respir; 1994; 11(4):421-3. PubMed ID: 7973044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of Kaposi's sarcoma in a Sudanese kidney transplant recipient after conversion to sirolimus: a focus on a common clinical problem.
    Yousif ME; El Hassan AM
    Arab J Nephrol Transplant; 2011 Jan; 4(1):49-52. PubMed ID: 21469595
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.
    Pranteda G; Feliziani G; Grimaldi M; Paleologo G; Pranteda G; Melotti F; Camplone G
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1022-3. PubMed ID: 18194240
    [No Abstract]   [Full Text] [Related]  

  • 19. Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression?
    al-Sulaiman MH; Mousa DH; Dhar JM; al-Khader AA
    Am J Nephrol; 1992; 12(5):384-6. PubMed ID: 1489012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bleomycin in Kaposi disease in a patient with heart transplantation].
    Modiano P; Mattei MF; Reichert S; Barbaud A; Weber M; Schmutz JL
    Ann Dermatol Venereol; 1996; 123(3):174-6. PubMed ID: 8761777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.